RetinalGenix acquires DNA/GPS for 2M shares; combines retinal imaging with genetic mapping

RetinalGenix Technologies Inc.

Acquired all outstanding shares of DNA/GPS Inc. in exchange for 2,000,000 shares of RTGN common stock.
DNA/GPS is a pharmacogenetics company based in Tampa, FL, founded by Dr. Lawrence Perich.
Combined platform aims to enable home-based screening and diagnosis of systemic diseases like heart disease, Alzheimer's, Parkinson's.
Dr. Perich to join advisory board; platform expected to reduce reliance on costly procedures like CT, MRI, PET.
Shares issued in private placement exempt from registration under Section 4(a)(2).

item 1.01 item 2.01 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.